Literature DB >> 387596

Immunization with major outer membrane proteins in experimental salmonellosis of mice.

N Kuusi, M Nurminen, H Saxen, M Valtonen, P H Mäkelä.   

Abstract

Porin (outer membrane protein) preparations extracted from a rough (Rb2) mutant of Salmonella typhimurium proved to be good immunogens in mice and rabbits. The antibody response achieved was measured by using enzyme-linked immunosorbent assay techniques. High titers of both antiporin and antilipopolysaccharide were detected in both species. The rabbit antiserum raised against the porins and the porin preparations themselves had a highly significant protective capacity against intraperitoneal Salmonella infection of mice. Absorption of the rabbit antiporin serum with lipopolysaccharide immunosorbent did not change its protective capacity in a passive immunization experiment, suggesting that the antiporin antibody preparations were the active components.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387596      PMCID: PMC414527          DOI: 10.1128/iai.25.3.857-862.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  THE PRESENT STATUS OF FIELD AND LABORATORY STUDIES OF TYPHOID AND PARATYPHOID VACCINES WITH SPECIAL REFERENCE TO STUDIES SPONSORED BY WORLD HEALTH ORGANIZATION.

Authors:  B CVJETANOVIC; K UEMURA
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

2.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Pneumococcal infection and pneumococcal vaccine.

Authors:  R Austrian
Journal:  N Engl J Med       Date:  1977-10-27       Impact factor: 91.245

5.  Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice.

Authors:  S E Greisman; J B DuBuy; C L Woodward
Journal:  Proc Soc Exp Biol Med       Date:  1978-07

6.  The outer membrane proteins of Gram-negative bacteria: biosynthesis, assembly, and functions.

Authors:  J M DiRienzo; K Nakamura; M Inouye
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

7.  Immunity to experimental Salmonella infection: studies on the protective capacity and immunogenicity of lipopolysaccharide, acetone-killed cells, and ribosome-rich extracts of Salmonella typhimurium in C3H/HeJ and CD-1 mice.

Authors:  T K Eisenstein; C R Angerman
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

8.  Protective effects of a supernatant factor from Salmonella typhimurium on Salmonella typhimurium infection of inbred mice.

Authors:  J Plant; A A Glynn; B M Wilson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

9.  Mouse virulence of Salmonella typhimurium mutants deficient in two major outer membrane proteins.

Authors:  M V Valtonen; M Nurminen; V Johansson; P H Makela
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

10.  Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.

Authors:  S B Svenson; M Nurminen; A A Lindberg
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

View more
  57 in total

1.  Adjuvanted outer membrane protein vaccine protects poultry against infection with Salmonella enteritidis.

Authors:  M Meenakshi; C S Bakshi; G Butchaiah; M P Bansal; M Z Siddiqui; V P Singh
Journal:  Vet Res Commun       Date:  1999-03       Impact factor: 2.459

2.  Pore-forming ability of major outer membrane proteins from Wolinella recta ATCC 33238.

Authors:  W L Kennell; C Egli; R E Hancock; S C Holt
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

3.  Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition.

Authors:  Alberto Diaz-Quiñonez; Natalia Martin-Orozco; Armando Isibasi; Vianney Ortiz-Navarrete
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 4.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

Review 5.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

6.  Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infection.

Authors:  V J Rapp; R F Ross
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.

Authors:  J W Killion; D C Morrison
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

8.  Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.

Authors:  H E Gilleland; M G Parker; J M Matthews; R D Berg
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

9.  Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins.

Authors:  M Galdiero; L De Martino; A Marcatili; I Nuzzo; M Vitiello; G Cipollaro de l'Ero
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

10.  Comparison of sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles and antigenic relatedness among outer membrane proteins of 49 Brucella abortus strains.

Authors:  D R Verstreate; A J Winter
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.